Join the Oncology Voice Network. Join for Free
How a "Non Traditional" background can lead to success as an MSL
Medical Science Liaison MSL career tips networking in medical affairs transitioning to industry non-traditional background success

How a "Non Traditional" background can lead to success as an MSL


Share This Article


Summary

In this episode, Robert Rosti shares his unique journey from medical information to becoming a Medical Science Liaison (MSL). He provides insights into the transition process, emphasizing the importance of networking and professional etiquette. Robert discusses how to leverage diverse backgrounds and offers tips for breaking into the MSL industry without prior experience. He highlights the significance of preparation, emotional intelligence, and mastering LinkedIn for effective networking. The conversation covers navigating the cultural shift from academia to industry and strategies for standing out with a nontraditional background. Robert also delves into interview techniques and the dedication required for a successful MSL career.

My guest today is Robert Rosti, Sr Medical Science Liaison at Biogen. He discusses how his "Non-Traditional" background led to great success as a Medical Science Liaison.

In this episode we discuss:

  • Rob’s background
  • His education and where his career began
  • What made him want to transition to the industry and how did he go about it?
  • How Rob landed in medical affairs and why he wanted to be an MSL?
  • His advice for others who may have a non-traditional background
  • What he feels is most important for ANYONE trying to transition into the industry and become an MSL?
  • His advice to those that are looking to build a career in Medical Affairs

Click for Source
Medical Science Liaison, MSL career tips, networking in medical affairs, transitioning to industry, non-traditional background success

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN